NAV
$4.91
AUM
$1.0B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.82
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +3.60% | -10.60% | +19.56% | +102.90% | -6.70% | -34.48% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | CURA | Curaleaf Holdings Inc | 12.28% |
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Inception Date: 2020-09-01